Endometrial Cancer
Showing 9976 - 10000 of >10,000
Triple-negative Breast Cancers in Order to Validate Interest of
Not yet recruiting
- Triple Negative Breast Cancer
- Organoid
- Establishment of ex vivo breast cancer organoid models
-
Caen, FranceCentre François Baclesse
Aug 9, 2022
Google Location History Following Oesophagectomy and/or
Recruiting
- Oesophageal Cancer
- +3 more
- Physical activity assessment
-
London, United KingdomImperial College London
Mar 30, 2022
Cancer, Tumor Malignant Trial in New Orleans (Multimedia Psychoeducational Intervention, Enhanced Usual Care)
Recruiting
- Cancer
- Neoplasm Malignant
- Multimedia Psychoeducational Intervention
- Enhanced Usual Care
-
New Orleans, Louisiana
- +1 more
Apr 25, 2022
Tear Based Sample Collection Breast Cancer Detection
Active, not recruiting
- Breast Cancer
- +2 more
- Melody®
-
Galveston, TexasUTMB Health
Mar 7, 2022
Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)
Recruiting
- Multiple Myeloma
- Immune System Diseases
- CAR138 T Cells
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 10, 2023
Sars-CoV2, Covid-19 Trial in Oklahoma City (mHealth Assessments)
Completed
- Sars-CoV2
- Covid-19
- mHealth Assessments
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 26, 2022
Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)
Active, not recruiting
- Small Cell Lung Cancer
- BMS-986012
- +4 more
-
Barcelona, Spain
- +3 more
Apr 25, 2022
Detection of Plasma Circulating Tumor DNA in Gastric Cancer
Recruiting
- Circulating Tumor DNA (ctDNA)
- Gastric Cancer
- plasma circulating tumor DNA
-
Ho Chi Minh City, VietnamUniversity Medical Center Ho Chi Minh City
Apr 27, 2022
Learn How Triple Class Refractory Multiple Myeloma Are Treated
Not yet recruiting
- Relapse Multiple Myeloma
- Refractory Multiple Myeloma
- (no location specified)
Feb 15, 2023
Advanced Solid Tumors or Triple-negative Breast Cancer Trial in Japan (Sacituzumab Govitecan-hziy)
Recruiting
- Advanced Solid Tumors or Triple-negative Breast Cancer
- Sacituzumab Govitecan-hziy
-
Aichi, Japan
- +21 more
Dec 1, 2022
Lymphedema, Edema Trial in Stanford, Chicago (BioBridge® Collagen Matrix, Vascularized Lymph Node Transfer (VLNT))
Recruiting
- Lymphedema
- Edema
- BioBridge® Collagen Matrix
- Vascularized Lymph Node Transfer (VLNT)
-
Chicago, IllinoisThe University of Chicago Biological Sciences Division/Universit
Jan 13, 2023
Breast Cancer Trial in Boston (Liposomal bupivacaine, Bupivacaine, epinephrine, dexamethasone, and clonidine)
Recruiting
- Breast Cancer
- Liposomal bupivacaine
- Bupivacaine, epinephrine, dexamethasone, and clonidine
-
Boston, MassachusettsTufts Medical Center
Jan 23, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)
Not yet recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Sacituzumab govitecan
- (no location specified)
Jan 23, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Portland (procedure, drug,
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- Metastatic Triple-Negative Breast Carcinoma
- Biopsy
- +6 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 29, 2022
Borderline Ovarian Serous Tumor, Micropapillary Serous Carcinoma, Ovarian Serous Adenocarcinoma Trial in United Kingdom, United
Active, not recruiting
- Borderline Ovarian Serous Tumor
- +5 more
- Letrozole
- +7 more
-
Huntsville, Alabama
- +507 more
Dec 27, 2021
Sarcoid, Cardiovascular Diseases, Cancer Trial in Boston ([64]Cu Macrin)
Recruiting
- Sarcoid
- +2 more
- [64]Cu Macrin
-
Boston, Massachusetts
- +1 more
Jun 22, 2022
Metastatic Castration-resistant Prostate Cancer Trial in China (TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- TQB3823 tablets
- +2 more
-
Chongqing, Chongqing, China
- +4 more
Jun 1, 2022
Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Chicago (Carboplatin,
Recruiting
- Human Papilloma Virus
- +4 more
- Carboplatin
- +7 more
-
Chicago, IllinoisUniversity Of Chicago Medicine Comprehensive Cancer Center
Jun 3, 2022
Incidental Cancer in Familial Adenomatous Polyposis
Completed
- Cancer
-
Gaziantep, TurkeyDr. Ersin Arslan Training and Resource Hospital
Dec 10, 2021
Cervical Cancer, Ovarian Cancer, Malignant Trophoblastic Tumor Trial (Toripalimab + ScTIL)
Not yet recruiting
- Cervical Cancer
- +2 more
- Toripalimab + ScTIL
- (no location specified)
Apr 17, 2022
Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in United States (ChemoID Assay, Standard Chemotherapy)
Recruiting
- Recurrent Ovarian Carcinoma
- Platinum-resistant Ovarian Cancer
- ChemoID Assay
- Standard Chemotherapy
-
Phoenix, Arizona
- +9 more
Oct 16, 2021
Colon Cancer, Rectal Cancer, Frailty Trial in Køge, Slagelse (Prehabilitation)
Recruiting
- Colon Cancer
- +2 more
- Prehabilitation
-
Køge, Danmark, Denmark
- +1 more
Mar 2, 2022
Mobile Sensor Technologies to Assess General Symptomology of
Enrolling by invitation
- Neoplasms
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil
Recruiting
- Superficial Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Combination cream of 5-fluorouracil and calcipotriene
- 5-fluorouracil cream
-
Boston, MassachusettsBoston Medical Center Dermatology Clinic
Nov 9, 2022